Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Quantum Leap Healthcare, G1 Therapeutics Announce Trilaciclib Evaluation

americanpharmaceuticalreviewJanuary 16, 2020

Tag: G1 Therapeutics , trilaciclib , I-SPY 2 , Breast Cancer

PharmaSources Customer Service